Clinical Trials Directory

Trials / Completed

CompletedNCT03490851

The Effect of a Breakfast Meal Containing Oat β-glucan on Food Intake at a Subsequent Meal in Normal-weight and Overweight Subjects

The Effect of a Breakfast Meal Containing Oat β-glucan on Food Intake at a Subsequent Meal in Normal-weight and Overweight Subjects: A Randomized, Placebo-controlled Cross-over Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
PepsiCo Global R&D · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The objectives of this study are to determine, in normal-weight and overweight subjects the effect of: Primary: oatmeal containing 4 g oat β-glucan on food intake at a subsequent meal compared to Cream of Rice cereal. Secondary: (i) oatmeal containing 2 g oat β-glucan on food intake at a subsequent meal compared to Cream of Rice cereal; and (ii) oatmeal containing 2g, 4g and 4g low MW oat beta-glucan on subjective appetite ratings, gastric emptying, postprandial responses of glucose, insulin, ghrelin and PYY levels compared to those elicited by Cream of Rice cereal. In addition, the relationship between amount, MW and viscosity of OBG and the primary and secondary objectives will be determined.

Conditions

Interventions

TypeNameDescription
OTHEROatmeal + OatWell28CF Int 1Intervention involves consumption of one cereal in the beginning of each visit of the crossover sequence.
OTHEROatmeal + OatWell28CF Int 2Intervention involves consumption of one cereal in the beginning of each visit of the crossover sequence.
OTHEROatmeal + OatWell28CF Int 3Intervention involves consumption of one cereal in the beginning of each visit of the crossover sequence.
OTHERCream of RiceIntervention involves consumption of one cereal in the beginning of each visit of the crossover sequence.

Timeline

Start date
2017-05-07
Primary completion
2017-11-28
Completion
2017-11-28
First posted
2018-04-06
Last updated
2019-12-02

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03490851. Inclusion in this directory is not an endorsement.